Loading data for TKNO — first visit, this takes a few seconds.
Alpha Teknova, Inc. (TKNO)
NasdaqGM: TKNO
· Real-Time Price · USD
6.92
-0.32 (-4.42%)
At close: Sep 04, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
Alpha Teknova, Inc. (TKNO) Stock Price, Analysis & Data
No data available
| Bid | 4.09 |
| Market Cap | 372M |
| Revenue (ttm) | 43.7M |
| Net Income (ttm) | -16.8M |
| 0.73 | |
| -0.31 | |
| n/a | |
| -36.42 | |
| P/B (ttm) | 5.93 |
| P/S (ttm) | 8.50 |
| Earnings Date | Nov 5, 2026 |
| Ask | 7.05 |
| Volume | 144,310 |
| Avg. Volume (20D) | 210,466 |
| Open | 7.15 |
| Previous Close | 7.24 |
| Day's Range | 6.82 - 7.15 |
| 52-Week Range | 1.91 - 7.84 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About TKNO
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. I...
Sector Healthcare
IPO Date Jun 25, 2021
Employees 158
Stock Exchange NasdaqGM
Ticker Symbol TKNO
Website https://www.teknova.com
Financial Performance
In 2025, Alpha Teknova's revenue was 40.52M, an increase of 7.35% compared to the previous year's 37.75M. Earnings were -17.26M, a decrease of -35.47%.
Financial StatementsEarnings Surprise
Alpha Teknova has released their quarterly earnings on Aug 5, 2026:
- Revenue of $12.19M misses estimates by $0, with 18.45% YoY growth.
- EPS of -0.05 exceeds estimates by 0.02, with 28.57% YoY growth.
Alpha Teknova, Inc. is scheduled to release its earnings on Nov 5, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2